Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1981 Oct 1;125(7):741–743.

Infant botulism in Canada.

D M McCurdy, C Krishnan, A H Hauschild
PMCID: PMC1862417  PMID: 7326656

Full text

PDF
743

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnon S. S., Chin J. The clinical spectrum of infant botulism. Rev Infect Dis. 1979 Jul-Aug;1(4):614–624. doi: 10.1093/clinids/1.4.614. [DOI] [PubMed] [Google Scholar]
  2. Arnon S. S., Midura T. F., Clay S. A., Wood R. M., Chin J. Infant botulism. Epidemiological, clinical, and laboratory aspects. JAMA. 1977 May 2;237(18):1946–1951. doi: 10.1001/jama.237.18.1946. [DOI] [PubMed] [Google Scholar]
  3. Arnon S. S., Midura T. F., Damus K., Thompson B., Wood R. M., Chin J. Honey and other environmental risk factors for infant botulism. J Pediatr. 1979 Feb;94(2):331–336. doi: 10.1016/s0022-3476(79)80863-x. [DOI] [PubMed] [Google Scholar]
  4. Brown L. W. Differential diagnosis of infant botulism. Rev Infect Dis. 1979 Jul-Aug;1(4):625–629. doi: 10.1093/clinids/1.4.625. [DOI] [PubMed] [Google Scholar]
  5. Clay S. A., Ramseyer J. C., Fishman L. S., Sedgwick R. P. Acute infantile motor unit disorder. Infantile botulism? Arch Neurol. 1977 Apr;34(4):236–243. doi: 10.1001/archneur.1977.00500160050009. [DOI] [PubMed] [Google Scholar]
  6. Gunn R. A. Epidemiologic characteristics of infant botulism in the United States, 1975-1978. Rev Infect Dis. 1979 Jul-Aug;1(4):642–646. doi: 10.1093/clinids/1.4.642. [DOI] [PubMed] [Google Scholar]
  7. Hauschild A. H., Bowmer E. J., Gauvreau L. Infant botulism. Can Med Assoc J. 1978 Mar 4;118(5):484–484. [PMC free article] [PubMed] [Google Scholar]
  8. Johnson R. O., Clay S. A., Arnon S. S. Diagnosis and management of infant botulism. Am J Dis Child. 1979 Jun;133(6):586–593. doi: 10.1001/archpedi.1979.02130060026004. [DOI] [PubMed] [Google Scholar]
  9. Metzger J. F., Lewis G. E., Jr Human-derived immune globulins for the treatment of botulism. Rev Infect Dis. 1979 Jul-Aug;1(4):689–692. doi: 10.1093/clinids/1.4.689. [DOI] [PubMed] [Google Scholar]
  10. Midura T. F. Laboratory aspects of infant botulism in California. Rev Infect Dis. 1979 Jul-Aug;1(4):652–655. doi: 10.1093/clinids/1.4.652. [DOI] [PubMed] [Google Scholar]
  11. Pickett J., Berg B., Chaplin E., Brunstetter-Shafer M. A. Syndrome of botulism in infancy: clinical and electrophysiologic study. N Engl J Med. 1976 Sep 30;295(14):770–772. doi: 10.1056/NEJM197609302951407. [DOI] [PubMed] [Google Scholar]
  12. Shield L. K., Wilkinson R. G., Ritchie M. Infant botulism in Australia. Med J Aust. 1978 Aug 12;2(4):157–157. doi: 10.5694/j.1326-5377.1978.tb131427.x. [DOI] [PubMed] [Google Scholar]
  13. Simpson L. L. The action of botulinal toxin. Rev Infect Dis. 1979 Jul-Aug;1(4):656–662. doi: 10.1093/clinids/1.4.656. [DOI] [PubMed] [Google Scholar]
  14. Turner H. D., Brett E. M., Gilbert R. J., Ghosh A. C., Liebeschuetz H. J. Infant botulism in England. Lancet. 1978 Jun 17;1(8077):1277–1278. doi: 10.1016/s0140-6736(78)91265-5. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES